Adelmidrol

DB16083InvestigationalSmall molecule

Adelmidrol is under investigation in clinical trial NCT01420510 (Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis).

Mechanism: Pharmacologically active on Peroxisome proliferator-activated receptor alpha and Peroxisome proliferator-activated receptor gamma
Curator reviewed
Formula / weight: C₁₃H₂₆N₂O₄ · 274.361 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyPAHZPHDAJQIETD-UHFFFAOYSA-NSMILESOCCNC(=O)CCCCCCCC(=O)NCCO

Targets

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Adelmidrol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.